These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6106445)

  • 1. Isoniazid hepatotoxicity and acetylation during tuberculosis chemoprophylaxis.
    Myles RK
    Am Rev Respir Dis; 1980 Sep; 122(3):505-6. PubMed ID: 6106445
    [No Abstract]   [Full Text] [Related]  

  • 2. Isoniazid chemoprophylaxis. Association with detection and incidence of liver toxicity.
    Byrd RB; Horn BR; Griggs GA; Solomon DA
    Arch Intern Med; 1977 Sep; 137(9):1130-3. PubMed ID: 332099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antitubercular chemoprevention: hepatotoxicity and therapeutic compliance].
    Hortoneda Giménez M; Alfonso Sánchez JL; Cortés Vizcaíno C; Sabater Pons A
    An Med Interna; 1993 Dec; 10(12):587-9. PubMed ID: 8049323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatotoxicity and transaminase measurement during isoniazid chemoprophylaxis in children.
    Palusci VJ; O'Hare D; Lawrence RM
    Pediatr Infect Dis J; 1995 Feb; 14(2):144-8. PubMed ID: 7746698
    [No Abstract]   [Full Text] [Related]  

  • 5. Incidence of hepatotoxicity in children receiving isoniazid chemoprophylaxis.
    Nakajo MM; Rao M; Steiner P
    Pediatr Infect Dis J; 1989 Sep; 8(9):649-50. PubMed ID: 2640548
    [No Abstract]   [Full Text] [Related]  

  • 6. [Elevated liver enzymes].
    Panther E; Blum HE
    MMW Fortschr Med; 2010 Sep; 152(37):34-5. PubMed ID: 21192451
    [No Abstract]   [Full Text] [Related]  

  • 7. Disturbed hepatic function during isoniazid chemoprophylaxis. Monitoring the hepatic function of 427 hospital employees receiving isoniazid chemoprophylaxis for tuberculosis.
    Bailey WC; Taylor SL; Dascomb HE; Greenberg HB; Ziskind MM
    Am Rev Respir Dis; 1973 Apr; 107(4):523-9. PubMed ID: 4697661
    [No Abstract]   [Full Text] [Related]  

  • 8. The hepatotoxicity of isoniazid among the three acetylator phenotypes.
    Ellard GA; Girling DJ; Nunn AJ
    Am Rev Respir Dis; 1981 May; 123(5):568-70. PubMed ID: 7235381
    [No Abstract]   [Full Text] [Related]  

  • 9. Isoniazid liver injury during chemoprophylaxis in children.
    Spyridis P; Sinaniotis C; Papadea I; Oreopoulos L; Hadjiyiannis S; Papadatos C
    Arch Dis Child; 1979 Jan; 54(1):65-7. PubMed ID: 420524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity of serum glutamic oxalacetic transaminase determinations in isoniazid recipients.
    Bailey WC; Taylor SL; Samuels MS; Dascomb HE; Ziskind M; DeRouen TA
    Am Rev Respir Dis; 1973 Apr; 107(4):670-2. PubMed ID: 4697675
    [No Abstract]   [Full Text] [Related]  

  • 11. [Liver toxicity of combined rifampicin-isoniazid-ethambutol medication (author's transl)].
    Austerhoff A; Kindler U; Knop P; Knieriem HJ
    Dtsch Med Wochenschr; 1974 May; 99(22):1182 p. PubMed ID: 4835559
    [No Abstract]   [Full Text] [Related]  

  • 12. Isoniazid plus rifampicin in the initial treatment of pulmonary tuberculosis.
    Clarke GB; Cuthbert J; Cuthbert RJ; Lees AW
    Br J Dis Chest; 1972 Oct; 66(4):268-71. PubMed ID: 5083434
    [No Abstract]   [Full Text] [Related]  

  • 13. Acetylation rates and monthly liver function tests during one year of isoniazid preventive therapy.
    Mitchell JR; Long MW; Thorgeirsson UP; Jollow DJ
    Chest; 1975 Aug; 68(2):181-90. PubMed ID: 1080096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis.
    Grönhagen-Riska C; Hellstrom PE; Fröseth B
    Am Rev Respir Dis; 1978 Sep; 118(3):461-6. PubMed ID: 707874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter: Isoniazid and the liver.
    Greenberg HB
    Am Rev Respir Dis; 1975 May; 111(5):708-9. PubMed ID: 1130761
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatotoxicity of rifampicin and isoniazid in children treated for tuberculosis.
    Linna O; Uhari M
    Eur J Pediatr; 1980 Sep; 134(3):227-9. PubMed ID: 6968680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-induced hepatotoxicity of anti-tuberculosis drugs and their serum levels.
    Jeong I; Park JS; Cho YJ; Yoon HI; Song J; Lee CT; Lee JH
    J Korean Med Sci; 2015 Feb; 30(2):167-72. PubMed ID: 25653488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical hepatotoxicity of isoniazid in children.
    Stein MT; Liang D
    Pediatrics; 1979 Oct; 64(4):499-505. PubMed ID: 492816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoniazid toxicity. A prospective study in secondary chemoprophylaxis.
    Byrd CB; Nelson R; Elliott RC
    JAMA; 1972 Jun; 220(11):1471-3. PubMed ID: 5067581
    [No Abstract]   [Full Text] [Related]  

  • 20. Fatal hepatic necrosis due to isoniazid chemoprophylaxis in a 15-year-old girl.
    Vanderhoof JA; Ament ME
    J Pediatr; 1976 May; 88(5):867-8. PubMed ID: 1271153
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.